Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab. [electronic resource]
Producer: 20200515Description: 21-23 p. digitalISSN:- 1879-0852
- Adult
- Anemia, Hemolytic, Autoimmune -- chemically induced
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antineoplastic Agents -- adverse effects
- B7-H1 Antigen -- immunology
- Carcinoma, Papillary -- drug therapy
- Carcinoma, Renal Cell -- drug therapy
- Female
- Humans
- Immunologic Factors -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Rituximab -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.